Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor

Molecular and Cellular Endocrinology

Volumn 127, Issue 1, 1997, Pages 27-40

  Nuñez, Susan B ^a   Medin, Jeffrey A ^b   Braissant, Olivier ^c   Kemp, Lawrence ^a   Wahli, Walter ^c   Ozato, Keiko ^b   Segars, James H ^a,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d NONE   (United States)

Author keywords

Estrogen receptors; Regulate; Transcription

Indexed keywords

ALITRETINOIN; ESTROGEN; ESTROGEN RECEPTOR; FATTY ACID; GUANINE; OXYTOCIN; PEROXISOME PROLIFERATOR; RETINOID X RECEPTOR; SULFUR 35;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; METHYLATION; NONHUMAN; PEROXISOME; PRECIPITATION; PRIORITY JOURNAL; PROMOTER REGION; REPRODUCTION; SEXUAL DEVELOPMENT; TUMOR;

CELL CULTURE TECHNIQUES; ESTROGENS; GENE EXPRESSION REGULATION; GENES, REGULATOR; GENES, REPORTER; GENETIC VECTORS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUCIFERASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0343742625     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(96)03980-9     Document Type: Article

References (76)

1. Colditz, G.A., Hankinson, S.E., Hunter, D.J., Willett, W.C., Manson, J.E., Stampfer, M.J., Hennekens, C., Rosner, B. and Speizer, F.E. (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 332, 1589-1593.
2. Pike, M.C., Spicer, D.V., Dahmoush, L. and Press, M.F. (1993) Estrogen, progestogens, normal breast cell proliferation and breast cancer risk. Epidemiol. Rev. 15, 17-35.
3. Bergkvist, L., Adami, H-O., Persson, I., Hoover, R. and Schairer, C. (1989) The risk of breast cancer after estrogen and estrogen-progestin replacement. N. Engl. J. Med. 321, 293-297.
4. Gorski, J., Furlow, J.D., Murdoch, F.E., Fritsch, M., Kaneko, K., Ying, C. and Malayer, J.R. (1993) Perturbations in the model of estrogen receptor regulation of gene expression. Biol. Reprod. 48, 8-14.
5. Christman, J.K., Nehls, S., Polin, L. and Brooks, S.C. (1995) Relationship between estrogen structure and conformational changes in estrogen receptor/DNA complexes. J. Steroid Biochem. Mol. Biol. 54, 201-210.
6. Zhuang, Y., Katzenellenbogen, B.S. and Shapiro, D.J. (1995) Estrogen receptor mutants that do not bind 17 beta-estradiol dimerize and bind to the estrogen response element in vivo. Mol. Endocrinol. 9, 457-466.
7. Beekman, J.M., Allan, G.F., Tsai, S.Y., Tsai, M.J. and O'Malley, B.W. (1993) Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol. Endocrinol. 7, 1266-1274.
8. Fritsch, M., Leary, C.M., Furlow, J.D., Ahrens, H., Schuh, T.J., Mueller, G.C. and Gorski, J. (1992) A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain. Biochemistry 31, 5303-5311.
9. Seiler-Tuyns, A., Walker, P., Martinez, E., Merillat, A.M., Givel, F. and Wahli, W. (1986) Identification of estrogen-responsive DNA sequences by transient expression expriments in a human breast cancer cell line. Nucleic Acids Res. 14, 8755-8770.
10. Klein-Hitpass, L., Tsai, SY., Greene, G.L., Clark, J.H., Tsai, M.J. and O'Malley, B.W. (1989) Specific binding of estrogen receptor to the estrogen response element. Mol. Cell. Biol. 9, 43-49.
11. Klein-Hitpass, L., Schorpp, M., Wagner, U. and Ryffel, G.U. (1986) An estrogen-responsive element derived from the 5″ flanking region of the xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46, 1053-1061.
12. Elliston, J.F., Fawell, S.E., Klein-Hitpass, L., Tsai, SY., Tsai, M.J., Parker, M.G. and O'Malley, B.W. (1990) Mechanism of estrogen receptor-dependent transcription in a cell-free system. Mol. Cell. Biol. 10, 6607-6612.
13. Ing, N.H., Beekman, J.M., Tsai, S.Y., Tsai, M-J. and O'Malley, B.W. (1992) Members of the steroid hormone receptor superfamily interact with TFIIB (5300-II). J. Biol. Chem. 267, 17617-17623.
14. Green, S. and Chambon, P. (1991) The oestrogen receptor: from perception to mechanism. In: Nuclear Hormone Receptors (Parker, M.G., ed.) pp. 1-13, Academic Press, London.
15. Korach, KS. (1994) Insights from the study of animals lacking functional estrogen receptor. Science 266, 1524-1527.
16. Toft, D. and Gorski, J. (1966) A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. Proc. Natl. Acad. Sci. USA 55, 1574-1581.
17. Glass, O.K., Holloway, J.M., Devary, O.V. and Rosenfeld, M.G. (1988) The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 54, 313-323.
18. Segars, J.H., Marks, M.S., Hirschfeld, S., Driggers, P.H., Martinez, E., Brown, M., Grippo, J.F., Wahli, W. and Ozato, K. (1993) Inhibition of estrogen-responsive gene activation by the retinoid x receptor b: evidence for multiple inhibitory pathways. Mol. Cell. Biol. 13, 2258-2268.
19. Burbach, J.P.H., Lopes da Silva, S., Cox, J.J., Adan, R.A.H., Cooney, A.J., Tsai, M.J. and Tsai, S.Y. (1994) Repression of estrogen-dependent stimulation of the oxytocin gene by chicken ovalbumin upstream promoter transcription factor I. J. Biol. Chem. 269, 15046-15053.
20. Tzukerman, M., Zhang, X.K. and Pfahl, M. (1991) Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradecanylphorbol-13-acetate: a molecular analysis. Mol. Endocrinol. 5, 1983-1992.
21. Ambrosino, C., Cicatiello, L., Cobellis, G., Addeo, R., Sica, V., Bresciani, F. and Weisz, A. (1993) Functional antagonism between the estrogen recpetor and fos in the regulation of c-fos protooncogene transcription. Mol. Endocrinol. 7, 1472-1483.
22. Jacq, X., Brou, C., Lutz, Y., Davidson, I., Chambon, P. and Tora, L. (1994) Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79, 107-117.
23. Martinez, E., Dusserre, Y., Wahli, W. and Mermod, N. (1991) Synergistic transcriptional activation by CTF/NF-1 and the estrogen receptor involves stabilized interactions with a limiting target factor. Mol. Cell. Biol. 11, 2937-2945.
24. Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C. and Brown, M. (1994) Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264, 1455-1458.
25. Baniahmad, C., Nawaz, Z., Baniahmad, A., Gleeson, M.A., Tsai, M-J. and O'Malley, B.W. (1995) Enhancement of human estrogen receptor activity by SPT6: a potential coactivator. Mol. Endocrinol. 9, 34-43.
26. Cavailles, V., Dauvois, S., Danielian, P.S. and Parker, M.G. (1994) Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA 91, 10009-10013.
27. Landel, C.C., Kushner, P.J. and Greene, G.L. (1994) The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Mol. Endocrinol. 8, 1407-1419.
28. Katzenellenbogen, J.A., O'Malley, B.W. and Katzenellenbogen, B.S. (1996) Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10, 119-131.
29. Keller, H., Givel, F., Perroud, M. and Wahli, W. (1995) Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid x receptor and estrogen receptor through estrogen response elements. Mol. Endocrinol. 9, 794-804.
30. Chawla, A. and Lazar, M.A. (1994) Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc. Natl. Acad. Sci. USA 91, 1786-1790.
31. Kliewer, S.A., Umesono, K., Noonan, D.J., Heyman, R.A. and Evans, R.M. (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771-774.
32. Shao, Z.M., Sheikh, M.S., Rishi, A.K., Dawson, M.l., Li, X-S., Wilber, J.F., Feng, P. and Fontana, J.A. (1995) Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation. Exp. Cell Res. 218, 1-8.
33. Sharif, M. and Privalsky, M.L. (1991) v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action. Cell 66, 885-893.
34. Rubin, M., Fenig, E., Rosenauer, A., Menendez-Botet, C., Achkar, C., Bentel, J.M., Yahalom, J., Mendelsohn, J. and Miller, W.H.Jr. (1994) 9-cis retinoic acid inhbits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res. 54, 6549-6556.
35. Schippers, l.J., Kloppenburg, M., Snippe, L. and AB, G. (1994) 9-cis-retinoic acid represses estrogen-induced expression of the very low density apolipoprotein II gene. Mol. Cell. Endocrinol. 105, 175-182.
36. Anzano, M.A., Byers, S.W., Smith, J.M., Peer, C.W., Mullen, L.T., Brown, C.C., Roberts, A.B. and Sporn, M.B. (1994) Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res. 54, 4614-4617.
37. Fontana, J.A. (1987) Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. Exp. Cell. Biol. 55, 136-144.
38. Sheikh, M.S., Shao, Z-M., Li, X-S., Dawson, M.I., Jetten, A.M., Wu, S., Conley, B.A., Garcia, M., Rochefort, H. and Fontana, J.A. (1994) Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-a acquire sensitivity to growth inhibition by retinoids. J. Biol. Chem. 269, 21 440-21 447.
39. Lippman, S.M., Benner, S.E. and Hong, W.K. (1993) Chemo-prevention: Strategies for the control of cancer. Cancer Suppl. 72, 984-990.
40. Sporn, M.B. and Roberts, A.B. (1985) Suppression of carcino-genesis by retinoids: interactons with peptide growth factors and their receptors as a key mechanism. Proc. Int. Symp. Princess Takamatsu Cancer Res. Fund 16, 149-158.
41. Hill, D.L. and Grubbs, C.J. (1982) Retinoids as chemopreventive and anticancer agents in intact animals (review). Anticancer Res. 1, 111-124.
42. Sporn, M.B., Roberts, AB., Roche, N.S., Kagechika, H. and Shudo, K. (1986) Mechanism of action of retinoids. J. Am. Acad. Dermatol. 15, 756-764.
43. Carroll, K.K. (1986) Experimental studies on dietary fat and cancer in relation to epidemiological data. Prog. Clin. Biol. Res. 222, 231-248.
44. Willett, W.C., Hunter, D.J., Stampfer, M.J., Colditz, G., Manson, J.E., Spiegelman, D., Rosner, B., Hennekens, C.H. and Speizer, F.E. (1992) Dietary fat and fiber in relation to risk of breast cancer. JAMA 268, 2037-2044.
45. McCay, P.B. and King, M. (1980) Interactions between dietary fats and antioxidants on DMBA-induced mammary carcinomas and on ΔAF-induced hyperplastic nodules and hepatomas. J. Environ. Pathol. Toxicol. 3, 451-465.
46. Schapira, D.V., Kumar, N.B., Lyman, G.H. and Cox, C.E. (1990) Abdominal obesity and breast cancer risk. Ann. Intern. Med. 112, 182-186.
47. Tontonoz, P., Hu, E., Graves, RA., Budavari, A.I. and Spiegelman, B.M. (1994) mPPARg2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234.
48. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G. and Wahli, W. (1992) Control of the peroxisomal B-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879-887.
49. Issemann, I. and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650.
50. Marcus, S.L., Miyata, K.S., Zhang, B., Subramani, S., Rachubinski, R.A. and Capone, J.P. (1993) Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc. Natl. Acad. Sci. USA 90, 5723-5727.
51. Beck, F., Plummer, S., Senior, P.V., Byrne, S., Green, S. and Brammar, W.J. (1992) The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat. Proc. R. Soc. London B 247, 83-87.
52. Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R., McPheat, W.L. and Green, S. (1992) The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J 11, 433-439.
53. Zhang, B., Marcus, S.L., Sajjadi, F.G., Alvares, K., Reddy, J.K., Subramani, S., Rachubinski, R.A. and Capone, J.P. (1992) Identification of a peroxisome proliferator-responsive element up-stream of the gene encoding rat peroxisomal enoyl-COA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc. NatI. Acad. Sci. USA 89, 7541-7545.
54. Gearing, K.L., Gottlicher, M., Teboul, M., Widmark, E. and Gustafsson, J.A. (1993) Interaction of the peroxisome-proliferator-activated receptor and retinoid x receptor. Proc. Natl. Acad. Sci. USA 90, 1440-1444.
55. Issemann, I., Prince, RA., Tugwood, J.D. and Green, S. (1993) The retinoid x receptor enhances the function of the peroxisome proliferator activated receptor. Biochimie 75, 251-256.
56. Keller, H., Mahfoudi, A., Dreyer, C., Hihi, A.K., Medin, J., Ozato, K. and Wahli, W. (1993) Peroxisome proliferator-activated receptors and lipid metabolism. Ann. New York Acad. Sci 684, 157-173.
57. Bulun, S.E., Mahendroo, M.S. and Simpson, E.R. (1994) Aromatase gene expression in adipose tissue: relationship to breast cancer. J. Steroid Biochem. Mol. Biol. 49, 319-326.
58. Nunez, S.B., Medin, J., Keller, H., Wang, K., Ozato, K., Wahli, W. and Segars, J. (1995) Retinoid x receptor B and peroxisome proliferator-activated receptor activate an estrogen response element. Rec. Prog. Horm. Res. 50, 409-416.
59. Therrien, M. and Droum, J. (1993) Molecular determinants for cell specificity and glucocorticoid repression of the proopiomelanocortin gene. Ann. New York Acad. Sci 680, 663-671.
60. Adan, R.A.H., Cox, J.J., Beischlag, T.V. and Burbach, J.P.H. (1993) A composite hormone response element mediates the transactivation of the rat oxytocin gene by different classes of nuclear hormone receptors. Mol. Endocrinol. 7, 47-57.
61. Hamada, K., Gleason, S.L., Levi, B-Z., Hirschfeld, S., Appella, E. and Ozato, K. (1989) H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility complex class I genes and the estrogen response element. Proc. Natl. Acad. Sci. USA 86, 8289-8293.
62. Forman, B.M. and Samuels, H.H. (1991) pEXPRESS: A family of expressin vectors containing a single transcription unit active in prokaryotes, eukaryotes and in vitro. Gene 105, 9-15.
63. Nagata, T., Segars, J.H., Levi, B-Z. and Ozato, K. (1992) Retinoic acid-dependent transactivation of major histocompatibility complex class I promoters by the nuclear hormone receptor H-2RIIBP in undifferentiated embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 89, 937-941.
64. Medin, J., Minucci, S., Driggers, P.H., Lee, l.J. and Ozato, K. (1994) Quantitative increases in DNA binding affinity and positional effects determine 9-cis retinoic acid induced activation of the retinoid x receptor B homodimer. Mol. Cell. Endocrinol. 105, 27-35.
65. Medin, J., Hunt, L., Gathy, K., Evans, R.K. and Coleman, M. (1990) Efficient, low-cost protein factories: expression of human adenosine deaminase in baculovirus-infected insect larvae. Proc. Natl. Acad. Sci. USA 87, 2760-2764.
66. Marks, M.S., Levi, B-Z., Segars, J.H., Driggers, P.H., Hirschfeld, S., Nagata, T., Appella, E. and Ozato, K. (1992) H-2RIIBP expressed from a baculovirus vector binds to multiple hormone response elements. Mol. Endocrinol. 6, 219-230.
67. Keller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K. and Wahli, W. (1993) Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid x receptor heterodimers. Proc. Nati. Acad. Sci. USA 90, 2160-2164.
68. Leng, X., Blanco, J., Tsai, S.Y., Ozato, K., O'Malley, B.W. and Tsai, M.J. (1995) Mouse retinoid x receptor contains a separable ligand-binding and transactivaton domain in its E region. Mol. Cell. Biol. 15, 255-263.
69. Zhang, X.K., Salbert, G., Lee, M.O. and Pfahl, M. (1994) Mutations that alter ligand-induced switches and dimerization activities in the retinoid x receptor. Mol. Cell. Biol. 14, 4311-4323.
70. Carlberg, C., Bendik, I., Wyss, A., Meier, E., Sturzenbecker, J., Grippo, J.F. and Hunziker, W. (1993) Two nuclear signalling pathways for vitamin D. Nature 361, 657-660.
71. Demirpence, E., Balaguer, P., Trousse, F., Nicolas, J-C., Pons, M. and Gagne, D. (1994) Antiestrogenic effects of all-trans retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanism. Cancer Res. 54, 1458-1464.
72. Colston, K.W., Chander, S.K., Mackay, A.G. and Coombes, R.C. (1992) Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem. Pharmacol. 44, 693-702.
73. Rier, S.E., Martin, D.C., Bowman, RE., Dmowski, W.P. and Backer, J.L. (1993) Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin. Fundam. Appl. Toxicol. 21, 433-441.
74. Moon, R.C., Thompson, H.J., Becci, P.J., Grubbs, C.J., Gander, R.J., Newton, D.L., Smith, J.M., Phillips, S.R., Henderson, W.R., Mullen, L.T., Brown, C.C. and Sporn, M.B. (1979) N-(4- hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res. 39, 1339-1346.
75. Lacroix, A. and Lippman, M.E. (1980) Binding of retinoids to human breast cancer cell lines and their effects on cell growth. J. Clin. Invest. 65, 586-591.
76. (1993) Facts and Figures, Amer. Cancer Society. Facts and Figures American Cancer Society.